Considered for decades as a contaminant of insulin preparations, gluca-gon was among the very first hormones to be isolated, purified, sequenced, and synthesized during the late 1950s. The field of glucagon research exploded after R.H. Unger and his colleagues in Dallas, TX, described a method permitting its measurement in the plasma by radioimmunoassay. Such assay made it possible to firmly establish the basic principles of glucagon physiology and to discover its pathophysiology. More recently, important progress has been made in exploring the molecular biology of this hormone: the glucagon gene and the glu-cagon-receptor gene have been identified and their expression investigated. Furthermore, the processing of the glucagon gene product has been elucidated and the function of the members of the glucagon family has been clarified. Finally, current investigations are in progress to develop glucagon agonists and antagonists and to identify new modes of administration of the hormone. These various topics will be considered in this review.
Skip Nav Destination
Article navigation
State of the Art Review|
May 01 1995
Glucagon and its Family Revisited
In Special Collection:
Review Articles
Pierre J Lefèbvre, MD, PHD, FRCP
Pierre J Lefèbvre, MD, PHD, FRCP
Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, University of Liège
Liège, Belgium
Search for other works by this author on:
Address correspondence and reprint requests to Pierre J. Lefèbvre, MD, Diabetes, Nutrition and Metabolic Disorders Unit, Centre Hospitalier Universitaire du Sart Turnan (B35), B-4000 Liège 1, Belgium.
Diabetes Care 1995;18(5):715–730
Article history
Received:
November 01 1994
Accepted:
December 22 1994
PubMed:
8586014
Citation
Pierre J Lefèbvre; Glucagon and its Family Revisited. Diabetes Care 1 May 1995; 18 (5): 715–730. https://doi.org/10.2337/diacare.18.5.715
Download citation file: